Tandem Diabetes Care, Inc.
TNDM
$19.14
$0.965.28%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.62% | 31.43% | 13.27% | 13.16% | -10.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.62% | 31.43% | 13.27% | 13.16% | -10.75% |
| Cost of Revenue | 20.96% | 24.46% | 15.86% | 12.17% | -1.41% |
| Gross Profit | 68.77% | 38.88% | 10.87% | 14.19% | -19.24% |
| SG&A Expenses | 20.47% | 25.60% | 12.85% | 0.33% | 3.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.06% | 24.36% | 14.53% | 6.82% | 3.59% |
| Operating Income | 98.43% | 17.28% | -24.55% | 15.06% | -593.91% |
| Income Before Tax | 100.05% | 26.41% | 14.11% | 68.01% | -94.30% |
| Income Tax Expenses | 43.50% | -71.46% | -6.54% | 1,010.10% | -401.15% |
| Earnings from Continuing Operations | 102.52% | 29.46% | 13.87% | 65.52% | -89.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.52% | 29.46% | 13.87% | 65.52% | -89.25% |
| EBIT | 98.43% | 17.28% | -24.55% | 15.06% | -593.91% |
| EBITDA | 111.06% | 20.49% | -30.43% | 17.60% | -1,832.79% |
| EPS Basic | 102.48% | 29.91% | 14.08% | 65.93% | -86.43% |
| Normalized Basic EPS | 105.98% | 26.86% | -34.82% | 15.66% | -792.18% |
| EPS Diluted | 102.48% | 29.91% | 14.08% | 65.93% | -86.43% |
| Normalized Diluted EPS | 105.95% | 26.86% | -34.82% | 15.66% | -792.18% |
| Average Basic Shares Outstanding | 0.87% | 0.65% | 0.25% | 1.20% | 1.53% |
| Average Diluted Shares Outstanding | 1.21% | 0.65% | 0.25% | 1.20% | 1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
